+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Sulphonamides Market by Form (Capsule, Liquid, Powder), Route of Administration (Oral, Topical), Distribution Channel, Application - Forecast 2024-2030- Product Image
Global Sulphonamides Market by Form (Capsule, Liquid, Powder), Route of Administration (Oral, Topical), Distribution Channel, Application - Forecast 2024-2030- Product Image
Sale

Global Sulphonamides Market by Form (Capsule, Liquid, Powder), Route of Administration (Oral, Topical), Distribution Channel, Application - Forecast 2024-2030

  • PDF Icon

    Report

  • 195 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5675148
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Sulphonamides Market size was estimated at USD 103.44 million in 2023, USD 108.52 million in 2024, and is expected to grow at a CAGR of 5.79% to reach USD 153.43 million by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Sulphonamides Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Sulphonamides Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Sulphonamides Market, highlighting leading vendors and their innovative profiles. These include AA Pharma Inc., Abbott Laboratories, AbbVie Inc., Bausch Health Companies Inc., Cadila Pharmaceuticals Ltd., Cipla Ltd., F. Hoffmann La Roche Ltd., Fera Science Limited, GlaxoSmithKline PLC, NorthStar Rx LLC, Novartis AG, Pfizer Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., and Viatris Inc.

Market Segmentation & Coverage

This research report categorizes the Sulphonamides Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Form
    • Capsule
    • Liquid
    • Powder
    • Tablets
  • Route of Administration
    • Oral
    • Topical
  • Distribution Channel
    • Online-Store Retailers
    • Store-Based Retailers
  • Application
    • Gastrointestinal Tract Infection
    • Respiratory Tract Infection
    • Skin Infections
    • Urinary Tract Infection
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Sulphonamides Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Sulphonamides Market?
  3. What are the technology trends and regulatory frameworks in the Sulphonamides Market?
  4. What is the market share of the leading vendors in the Sulphonamides Market?
  5. Which modes and strategic moves are suitable for entering the Sulphonamides Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Sulphonamides Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of chronic diseases worldwide
5.1.1.2. Substantial availability of affordable sulfonamide drug formulations
5.1.1.3. Awareness regarding sulpha drugs and its therapeutic uses
5.1.2. Restraints
5.1.2.1. Side effects of sulphonamides
5.1.3. Opportunities
5.1.3.1. Increasing research & development in pharmaceutical companies
5.1.3.2. Rapidly advancing medical tourism industry
5.1.4. Challenges
5.1.4.1. Lack of regulatory structure in emerging economies
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization
6. Sulphonamides Market, by Form
6.1. Introduction
6.2. Capsule
6.3. Liquid
6.4. Powder
6.5. Tablets
7. Sulphonamides Market, by Route of Administration
7.1. Introduction
7.2. Oral
7.3. Topical
8. Sulphonamides Market, by Distribution Channel
8.1. Introduction
8.2. Online-Store Retailers
8.3. Store-Based Retailers
9. Sulphonamides Market, by Application
9.1. Introduction
9.2. Gastrointestinal Tract Infection
9.3. Respiratory Tract Infection
9.4. Skin Infections
9.5. Urinary Tract Infection
10. Americas Sulphonamides Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Sulphonamides Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Sulphonamides Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. AA Pharma Inc.
14.1.2. Abbott Laboratories
14.1.3. AbbVie Inc.
14.1.4. Bausch Health Companies Inc.
14.1.5. Cadila Pharmaceuticals Ltd.
14.1.6. Cipla Ltd.
14.1.7. F. Hoffmann La Roche Ltd.
14.1.8. Fera Science Limited
14.1.9. GlaxoSmithKline PLC
14.1.10. NorthStar Rx LLC
14.1.11. Novartis AG
14.1.12. Pfizer Inc.
14.1.13. Sanofi S.A.
14.1.14. Teva Pharmaceutical Industries Ltd.
14.1.15. Viatris Inc.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. SULPHONAMIDES MARKET RESEARCH PROCESS
FIGURE 2. SULPHONAMIDES MARKET SIZE, 2022 VS 2030
FIGURE 3. SULPHONAMIDES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. SULPHONAMIDES MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. SULPHONAMIDES MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. SULPHONAMIDES MARKET DYNAMICS
FIGURE 7. SULPHONAMIDES MARKET SIZE, BY FORM, 2022 VS 2030 (%)
FIGURE 8. SULPHONAMIDES MARKET SIZE, BY FORM, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2022 VS 2030 (%)
FIGURE 10. SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2030 (%)
FIGURE 12. SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 14. SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS SULPHONAMIDES MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 16. AMERICAS SULPHONAMIDES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES SULPHONAMIDES MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 18. UNITED STATES SULPHONAMIDES MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC SULPHONAMIDES MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC SULPHONAMIDES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA SULPHONAMIDES MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA SULPHONAMIDES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 23. SULPHONAMIDES MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 24. SULPHONAMIDES MARKET SHARE, BY KEY PLAYER, 2022
List of Tables
TABLE 1. SULPHONAMIDES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. SULPHONAMIDES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SULPHONAMIDES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 6. SULPHONAMIDES MARKET SIZE, BY CAPSULE, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. SULPHONAMIDES MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. SULPHONAMIDES MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. SULPHONAMIDES MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 11. SULPHONAMIDES MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. SULPHONAMIDES MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 14. SULPHONAMIDES MARKET SIZE, BY ONLINE-STORE RETAILERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. SULPHONAMIDES MARKET SIZE, BY STORE-BASED RETAILERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 17. SULPHONAMIDES MARKET SIZE, BY GASTROINTESTINAL TRACT INFECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. SULPHONAMIDES MARKET SIZE, BY RESPIRATORY TRACT INFECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. SULPHONAMIDES MARKET SIZE, BY SKIN INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. SULPHONAMIDES MARKET SIZE, BY URINARY TRACT INFECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS SULPHONAMIDES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 29. ARGENTINA SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 31. BRAZIL SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 32. BRAZIL SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 33. BRAZIL SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 34. CANADA SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 35. CANADA SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 36. CANADA SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 37. CANADA SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. MEXICO SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 39. MEXICO SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 40. MEXICO SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 41. MEXICO SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES SULPHONAMIDES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 47. ASIA-PACIFIC SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 48. ASIA-PACIFIC SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 50. ASIA-PACIFIC SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. ASIA-PACIFIC SULPHONAMIDES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 52. AUSTRALIA SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 53. AUSTRALIA SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 54. AUSTRALIA SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 55. AUSTRALIA SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. CHINA SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 57. CHINA SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 58. CHINA SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 59. CHINA SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. INDIA SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 61. INDIA SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 62. INDIA SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 63. INDIA SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. INDONESIA SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 65. INDONESIA SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 66. INDONESIA SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 67. INDONESIA SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. JAPAN SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 69. JAPAN SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 70. JAPAN SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 71. JAPAN SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. MALAYSIA SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 73. MALAYSIA SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 74. MALAYSIA SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 75. MALAYSIA SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. PHILIPPINES SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 77. PHILIPPINES SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 78. PHILIPPINES SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 79. PHILIPPINES SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. SINGAPORE SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 81. SINGAPORE SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 82. SINGAPORE SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 83. SINGAPORE SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. SOUTH KOREA SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 85. SOUTH KOREA SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 86. SOUTH KOREA SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 87. SOUTH KOREA SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. TAIWAN SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 89. TAIWAN SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 90. TAIWAN SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 91. TAIWAN SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. THAILAND SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 93. THAILAND SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 94. THAILAND SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 95. THAILAND SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. VIETNAM SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 97. VIETNAM SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 98. VIETNAM SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 99. VIETNAM SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA SULPHONAMIDES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 105. DENMARK SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 106. DENMARK SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 107. DENMARK SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 108. DENMARK SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. EGYPT SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 110. EGYPT SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 111. EGYPT SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 112. EGYPT SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. FINLAND SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 114. FINLAND SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 115. FINLAND SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 116. FINLAND SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. FRANCE SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 118. FRANCE SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 119. FRANCE SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 120. FRANCE SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. GERMANY SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 122. GERMANY SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 123. GERMANY SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 124. GERMANY SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. ISRAEL SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 126. ISRAEL SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 127. ISRAEL SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 128. ISRAEL SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. ITALY SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 130. ITALY SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 131. ITALY SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 132. ITALY SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. NETHERLANDS SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 134. NETHERLANDS SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 135. NETHERLANDS SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 136. NETHERLANDS SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. NIGERIA SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 138. NIGERIA SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 139. NIGERIA SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 140. NIGERIA SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. NORWAY SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 142. NORWAY SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 143. NORWAY SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 144. NORWAY SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. POLAND SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 146. POLAND SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 147. POLAND SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 148. POLAND SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. QATAR SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 150. QATAR SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 151. QATAR SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 152. QATAR SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 156. RUSSIA SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 160. SAUDI ARABIA SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. SPAIN SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 166. SPAIN SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 167. SPAIN SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 168. SPAIN SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. SWEDEN SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 170. SWEDEN SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 171. SWEDEN SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 172. SWEDEN SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. SWITZERLAND SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 174. SWITZERLAND SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 175. SWITZERLAND SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 176. SWITZERLAND SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 177. TURKEY SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 178. TURKEY SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 179. TURKEY SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 180. TURKEY SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM SULPHONAMIDES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM SULPHONAMIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM SULPHONAMIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 188. UNITED KINGDOM SULPHONAMIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. SULPHONAMIDES MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 190. SULPHONAMIDES MARKET SHARE, BY KEY PLAYER, 2022
TABLE 191. SULPHONAMIDES MARKET LICENSE & PRICING

Companies Mentioned

  • AA Pharma Inc.
  • Abbott Laboratories
  • AbbVie Inc.
  • Bausch Health Companies Inc.
  • Cadila Pharmaceuticals Ltd.
  • Cipla Ltd.
  • F. Hoffmann La Roche Ltd.
  • Fera Science Limited
  • GlaxoSmithKline PLC
  • NorthStar Rx LLC
  • Novartis AG
  • Pfizer Inc.
  • Sanofi S.A.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages195
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 108.52 Million
Forecasted Market Value ( USD ) by 2030 $ 153.43 Million
Compound Annual Growth Rate5.7%
Regions CoveredGlobal
No. of Companies Mentioned15

Related Topics

Related Reports

Global Sulphonamides Market - Product Image

Global Sulphonamides Market

  • Report
  • 200 Pages
  • Global
From
Sulphonamides Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Sulphonamides Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 91 Pages
  • Global
From
World - Sulphonamides - Market Analysis, Forecast, Size, Trends and Insights - Product Image

World - Sulphonamides - Market Analysis, Forecast, Size, Trends and Insights

  • Report
  • Global
From
Global Vancomycin Market by Type (Ampicillin, Chloramphenicol, Daptomycin), Form (Capsule, Oral Solution (Liquid), Powder), Route of Administration, Application, Distribution Channel - Forecast 2024-2030 - Product Image

Global Vancomycin Market by Type (Ampicillin, Chloramphenicol, Daptomycin), Form (Capsule, Oral Solution (Liquid), Powder), Route of Administration, Application, Distribution Channel - Forecast 2024-2030

  • Report
  • 197 Pages
  • Global
From
Global Antibiotics Market by Action Mechanism, Drug Class, Spectrum, Category, Application, Route of Administration, Distribution Channel - Forecast 2024-2030 - Product Image

Global Antibiotics Market by Action Mechanism, Drug Class, Spectrum, Category, Application, Route of Administration, Distribution Channel - Forecast 2024-2030

  • Report
  • 192 Pages
  • Global
From

About the Sulfonamide Market

Sulfonamide is a type of antibiotic used to treat bacterial infections. It works by inhibiting the growth of bacteria, preventing them from reproducing and spreading. Sulfonamide is used to treat a wide range of bacterial infections, including urinary tract infections, skin infections, and respiratory infections. It is also used to prevent certain types of malaria. Sulfonamide is available in both oral and intravenous forms, and is often used in combination with other antibiotics. Sulfonamide is a widely used antibiotic, and is often prescribed as a first-line treatment for bacterial infections. It is generally well-tolerated, with few side effects. However, it is not effective against all types of bacteria, and some bacteria have developed resistance to it. Some companies in the Sulfonamide market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and Novartis. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.